The 2011 ESRD prospective payment system: Perspectives from DaVita, a for-profit large dialysis organization

American Journal of Kidney Diseases

Volumn 57, Issue 4, 2011, Pages 550-552

  Nissenson, Allen R ^a   Mayne, Tracy J ^a   Krishnan, Mahesh ^a  

^a DAVITA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTIINFECTIVE AGENT; ANTIPRURITIC AGENT; ANXIOLYTIC AGENT;

CLINICAL PRACTICE; DIALYSIS; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; KIDNEY FAILURE; MEDICAID; MEDICARE; REVIEW;

EID: 79952992385     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.01.009     Document Type: Editorial

References (5)

1. Centers for Medicare & Medicaid Services End-Stage Renal Disease Prospective Payment System Fed Regist 75 155 2010 49029 49214 http://federalregister.gov/a/2010-18466 Accessed August 12, 2010
2. A.R. Nissenson, T.J. Mayne, and M. Krishnan The 2009 proposed rule for prospective ESRD payment: perspectives from a large dialysis organization Am J Kidney Dis 55 2 2010 223 226
3. T. Mayne Dissecting the bundle: the final rules for the prospective payment system for dialysis Nephrol News Issues 24 10 2010 14 16, 18-19
4. T.J. Mayne, M. Burgess, and J. Weldon Finding the case mix adjusters in the CMS proposed bundle Nephrol News Issues 10 2009 34 38
5. Kidney Care Council Memorandum from The Moran Company Modeling the transition budget neutrality adjustor for the ESRD prospective payment system (PPS) final data www.nephronline.com/uploaded/transition%20adjustor.pdf Accessed November 2, 2010